Navigating the financial commitment of metabolic health treatments can be daunting for self-pay consumers. Evaluating telehealth platforms like those detailed in our comprehensive Hims/Hers review reveals that understanding the exact breakdown of membership fees, prescription costs, and hidden exclusions is essential before starting your journey. Designated as a Strong Choice under our independent evaluation framework (detailed further in our review methodology), Hims & Hers offers a structured digital health experience for individuals seeking medical weight loss. However, out-of-pocket expenses vary significantly depending on whether you choose brand-name medications like Ozempic, Wegovy, or Zepbound, or compounded alternatives such as compounded semaglutide or generic liraglutide.
In this exhaustive 2026 cost report, we analyze the exact pricing architecture of the Hims and Hers weight loss programs. We examine upfront promotional rates, recurring subscription fees, pharmacy fulfillment pricing, geographic availability nuances, and what is included versus excluded in your monthly investment. By examining these financial metrics alongside peer comparisons (such as those found in our cheapest GLP-1 programs guide and our Ro cost and pricing analysis), you can make an informed, confident decision aligned with your personal healthcare budget.
Hims and Hers Weight Loss Program Overview: The Financial Baseline
Hims, Inc. operates as a publicly traded telehealth pioneer (NYSE: HIMS). Over the past several years, the company has expanded its digital clinical offerings from dermatological and sexual wellness treatments into robust metabolic health and weight management programs.
For self-pay consumers navigating out-of-pocket weight loss solutions, Hims and Hers positions itself as a streamlined, app-based provider emphasizing accessibility, asynchronous medical consultations, and ongoing digital support. However, public consumer sentiment is mixed: consumer review aggregates on platforms such as Trustpilot report an average score of 3.0 out of 5 across more than 8,000 user reviews, highlighting common debates regarding subscription renewals, customer service responsiveness, and medication availability.
A critical milestone in the company's 2026 trajectory is its official partnership with Novo Nordisk, announced in March 2026. This partnership has strengthened Hims' direct access to authentic brand-name medications alongside its established compounding partnerships. Below, we dissect every layer of the financial commitment required to participate in the program.
Membership Fee Structure: Upfront Costs and Recurring Subscriptions
Unlike traditional brick-and-mortar weight loss clinics that charge steep per-visit fees or require expensive initial lab panels, Hims and Hers utilizes a subscription-based telehealth model.
The Introductory Pricing Model
- First Month Promotional Rate: New patients can enroll for an introductory rate of $39 for the first month. This initial fee covers the comprehensive digital onboarding process, medical intake evaluation, clinician review, and initial treatment planning.
- Standard Recurring Membership: Following the introductory promotional period, the standard recurring membership fee is $149 per month.
What the Membership Fee Covers
The $149 monthly membership fee acts as the operational backbone of your ongoing care within the Hims or Hers app ecosystem. It includes:
- Asynchronous Medical Consultations: Ongoing access to licensed medical providers who review your progress, adjust treatment plans, and answer clinical questions via secure messaging.
- 24/7 App Access: Continuous availability of the proprietary Hims/Hers mobile application for tracking habits, logging doses, and communicating with care coordinators.
- Prescription Management & Refill Coordination: Automated refill management and coordination with partner compounding pharmacies or brand-name fulfillment centers.
- Structured Patient Education & Safety Protocols: Access to a rigorous clinical onboarding journey: including a 38-screen intake questionnaire spread across 12 distinct stages that takes approximately 7 minutes to complete, featuring a standout eating-disorder safety screening flow designed to screen out ineligible or at-risk individuals.
Important Membership Exclusions
Transparency is core to our evaluation methodology. Consumers must note what the standard membership fee does not include:
- Medication Costs: The $149 monthly subscription fee does not include the cost of the medication itself. Prescriptions are billed separately.
- Lab Testing: Hims and Hers does not include baseline or ongoing lab testing in its standard membership fee. If your prescribing clinician requires blood work (such as metabolic panels, HbA1c, or thyroid function tests), you must obtain these independently through your primary care physician or a commercial lab service, which incurs out-of-pocket costs.
- Dietitian or Nutritionist Access: Unlike specialized clinical obesity medicine programs, dedicated 1-on-1 registered dietitian coaching is not bundled into the standard membership tier. Nutritional guidance is delivered primarily through automated app content and general asynchronous advice.
Medication Pricing: Brand-Name vs. Compounded Options
The most significant variable in your total monthly out-of-pocket expense with Hims and Hers is the specific medication prescribed by your clinician. Treatment plans are tailored based on clinical eligibility, supply availability, and patient preference among the available formulary options:
- Brand-Name Options: Ozempic (semaglutide), Wegovy (semaglutide), and Zepbound (tirzepatide). Thanks to supply stabilization and strategic manufacturing partnerships: such as the March 2026 Novo Nordisk collaboration: access to brand-name medications has improved, though cash-pay prices for brand-name injectables remain high across the telehealth industry, typically ranging from $900 to $1,300+ per month depending on dosage and pharmacy pricing.
- Compounded Options: Compounded semaglutide and generic liraglutide. For self-pay consumers seeking more affordable pathways, compounded formulations prepared by specialized 503A or 503B compounding pharmacies offer substantial savings. Compounded semaglutide through Hims and Hers generally reduces total monthly costs significantly compared to brand-name retail pricing, bundling medication fulfillment directly into simplified billing tiers.
Medication Pricing Breakdown Table
| Medication Type | Specific Drugs Available | Estimated Monthly Medication Cost (Self-Pay) | Pharmacy Fulfillment Source | Lab Requirement |
|---|---|---|---|---|
| Brand-Name Injectables | Ozempic, Wegovy, Zepbound | $900 – $1,350+ / mo | Commercial retail & specialty pharmacies | Clinician-dependent |
| Compounded Formulations | Compounded Semaglutide | Bundled or tiered (varies by plan) | Partner 503A/503B compounding pharmacies | Clinician-dependent |
| Daily Injectable Alternatives | Generic Liraglutide | Varies by dosage and supply | Partner pharmacies | Clinician-dependent |
Note: Exact medication pricing is subject to periodic adjustment based on pharmacy supply chain dynamics, active compounding regulations, and specific dosage titrations required during your weight loss journey.
Total Out-of-Pocket Costs and Year-Long Projections
To evaluate the true financial commitment of enrolling in the Hims or Hers weight loss program, consumers must calculate the cumulative out-of-pocket expenditure across a 12-month treatment horizon. Because GLP-1 and metabolic health treatments are chronic, long-term interventions, short-term promotional pricing can be misleading.
Calculating Month 1 Expenses
- Introductory Membership: $39
- Medication Fulfillment (Compounded Tier Estimate): Varies by active formulation
- Total Month 1 Estimate: Starting as low as promotional entry levels plus medication costs.
Calculating Months 2 Through 12 Expenses
- Standard Membership ($149/mo × 11 months): $1,639
- Annual Medication Costs: Dependent on whether you utilize compounded semaglutide or brand-name Wegovy/Zepbound.
- Independent Lab Testing (If required externally): $150 – $400 annually.
Year-Long Financial Projections Table
| Expenditure Category | Compounded Semaglutide Pathway (Estimated Annual) | Brand-Name Wegovy / Zepbound Pathway (Estimated Annual) |
|---|---|---|
| Membership Fees (Year 1) | ~$1,678 (incl. $39 first month) | ~$1,678 (incl. $39 first month) |
| Medication Costs (12 Months) | Varies by pharmacy tier | $10,800 – $15,600+ |
| Lab Work & Ancillary Costs | $0 – $300 (external) | $0 – $300 (external) |
| Estimated Total First-Year Cost | Moderate (Accessible Self-Pay) | High (Premium Brand-Name Investment) |
Geographic Availability and State-by-State Constraints
A vital consideration for prospective members is state-by-state regulatory compliance. While Hims and Hers operates nationally as a publicly traded enterprise, telehealth regulations and compounding pharmacy laws vary significantly across U.S. jurisdictions.
- Not Available in All 50 States: Due to state-specific medical board rules regarding asynchronous prescribing, telehealth controlled substance regulations, and state-level compounding pharmacy shipping restrictions, Hims and Hers weight loss programs are not available in every U.S. state.
- Verification Protocol: During the 38-screen digital intake process, the platform verifies your geographic location in real-time. If services or specific compounded medications are restricted in your state, the platform will notify you prior to billing. Consumers should always verify current state eligibility directly on the official Hims or Hers portal before committing to a membership.
How Hims Compares to Other Strong Choice Providers
Within the GLP-1.Reviews directory, Hims and Hers holds a Strong Choice tier designation. This classification reflects a provider that is generally reliable, backed by strong corporate stability (NYSE: HIMS), and a robust app-based user experience, while acknowledging minor tradeoffs such as a 3.0/5 Trustpilot average, the exclusion of lab work from base fees, and limited state availability.
How does its pricing and service model compare to other prominent Strong Choice or Top Tier competitors in the telehealth landscape?
- Ro: Ro offers structured metabolic programs with comprehensive digital tools, though pricing structures and lab inclusion policies differ. (Read our detailed Ro cost and pricing analysis).
- Mochi Health & Ivim Health: Programs that often bundle dietitian support or include different lab integration models, appealing to patients who prioritize high-touch nutritional coaching over purely app-driven asynchronous care.
- General Market Positioning: Hims and Hers is best suited for self-pay consumers who value brand reputation, public market accountability, rapid onboarding (via their 7-minute, 12-stage intake flow), and a clean digital app experience, and who do not require dedicated 1-on-1 registered dietitian counseling or bundled lab work.
Cost-Saving Strategies and Insurance
For many readers, the biggest question is not simply “What is the monthly fee?” but “How do I reduce my actual out-of-pocket cost?” That is especially important with Hims and Hers because the platform is built primarily for self-pay buyers rather than for patients moving through a traditional in-network insurance workflow.
Hims and Hers Is Primarily a Self-Pay Program
The core financial reality is straightforward: Hims and Hers does not currently bill insurance directly for its weight loss membership in the same way a traditional in-network medical practice might. In practical terms, that means most patients should approach the program as an out-of-pocket purchase rather than assuming their health plan will be charged automatically for visits, coaching, or prescription management.
That self-pay structure has tradeoffs:
- Advantage: Faster checkout, simpler onboarding, and fewer insurer-related delays.
- Tradeoff: Patients shoulder more of the administrative burden if they want to pursue reimbursement or use tax-advantaged healthcare funds.
- Budget impact: The membership fee remains a predictable recurring charge, but medication costs can still vary significantly depending on whether the prescription is compounded or brand-name.
For many cash-pay consumers, this is not necessarily a drawback. In fact, it is part of the platform’s appeal. People who are frustrated by prior authorizations, step therapy requirements, or insurance denials often choose Hims and Hers precisely because it offers a cleaner digital buying experience. The tradeoff is that convenience does not automatically equal lower total cost.
What “Self-Pay” Really Means Month to Month
A self-pay GLP-1 program works differently from a PCP visit that gets routed through your insurance card. With Hims and Hers, you should generally plan for three separate cost buckets:
- Membership fees: The first-month promotional rate and then the recurring subscription.
- Medication costs: Separate and highly variable depending on the drug prescribed.
- External clinical costs when needed: Labs, follow-up testing, or other care obtained outside the platform.
That distinction matters because some telehealth providers advertise a low entry price while shifting meaningful costs into medication fulfillment, labs, or support add-ons. Hims and Hers is relatively transparent about the fact that the membership fee is not the same thing as the medication price. For budgeting purposes, readers should evaluate the all-in monthly spend, not just the subscription headline.
HSA and FSA Considerations
Patients paying out of pocket often ask whether they can use Health Savings Account (HSA) or Flexible Spending Account (FSA) funds. In many cases, telehealth medical services and prescribed medications may be eligible healthcare expenses under HSA/FSA rules, but eligibility depends on your specific account administrator, card restrictions, documentation standards, and how the expense is coded.
In practice, that means:
- The membership fee may or may not be reimbursable, depending on whether your HSA/FSA administrator treats it as a qualifying medical expense.
- Prescription medication costs are often more clearly eligible when they are tied to a legitimate prescription and proper documentation.
- Patients may need to save itemized receipts, clinician documentation, and pharmacy records if their plan requires substantiation.
- Some HSA/FSA debit cards work directly at checkout, while others require you to pay first and submit for reimbursement later.
Because Hims and Hers does not operate like a conventional insurer-billed clinic, patients should not assume every charge will pass automatically through an HSA/FSA system without review. The safest approach is to verify the expense rules with your benefits administrator before enrollment and to retain every receipt related to membership charges, prescription fills, and any external lab work.
Insurance Reimbursement: Possible, but Not the Default Experience
Some readers also wonder whether they can submit invoices or superbills to insurance on their own. The answer is that this depends heavily on the service provided, the documentation available, and the rules of your individual plan. Hims and Hers is not framed in this article as a plug-and-play insurance-first obesity clinic. It is better understood as a convenience-focused self-pay platform.
That distinction matters because patients who want hands-on insurance support may prefer a provider with a more explicit insurance-concierge model. If your main goal is maximizing the chance of brand-name GLP-1 coverage through your insurer, Hims and Hers may not feel as optimized for that process as a provider whose workflow is built around prior authorizations and benefits navigation.
The March 2026 Novo Nordisk Partnership: Why It Matters for Cost
A major development for the Hims and Hers pricing story is the March 2026 Novo Nordisk partnership. This relationship matters less because it magically makes GLP-1 therapy cheap and more because it may improve the platform’s ability to connect eligible patients with authentic, brand-name Novo Nordisk supply in a more structured way.
From a patient-cost perspective, the partnership can influence the experience in several ways:
- Brand-name access may become more stable than during prior shortage-driven periods.
- Availability visibility may improve, helping patients understand whether brand-name options are realistically obtainable through the platform.
- Pricing may remain premium, because official supply access does not automatically mean low cash-pay pricing.
- Compounded-versus-brand decision-making becomes more important, since some patients may now have a clearer path to choosing between lower-cost compounded options and higher-cost brand-name medication.
Readers should be careful not to overinterpret the partnership. It does not mean Hims and Hers has suddenly become a low-cost brand-name GLP-1 provider. Wegovy and other branded GLP-1 products remain expensive in cash-pay channels across the market. What the partnership may do is reduce some uncertainty around sourcing and availability, which can still be valuable for patients who prefer manufacturer-backed supply over compounded alternatives.
Practical Ways to Reduce Total Spend
If you are considering Hims and Hers, several budget strategies can help reduce surprises:
- Confirm whether compounded or brand-name medication is the likely pathway before enrolling, since that decision will drive most of your actual cost.
- Ask what is included in your quoted plan price and whether medication billing is bundled or separate.
- Budget for labs independently if you do not already have recent bloodwork available through your primary care clinician.
- Use HSA/FSA funds when eligible to reduce the after-tax cost of care.
- Track renewal dates carefully so your subscription timing does not catch you off guard.
- Compare Hims and Hers against providers that bundle more services, especially if you expect to need lab coordination, dietitian support, or insurance assistance.
For self-pay patients who prioritize a polished app, fast onboarding, and a public-company telehealth brand, Hims and Hers may still represent solid value. But value depends on the full care package you need, not just the first-month promotional price.
What Real Patients Report
Pricing tables explain only part of the buying decision. The other part is what happens after checkout: billing clarity, refill timing, support responsiveness, and whether patients feel the experience matches the marketing. That is where Hims and Hers generates more mixed feedback than its corporate profile alone might suggest.
As noted earlier, public review aggregates show an average Trustpilot score of 3.0 out of 5 across more than 8,000 reviews. That is not an automatic disqualifier, but it does tell prospective buyers to look beyond the landing-page pitch. A 3.0/5 profile usually signals meaningful operational friction alongside a substantial number of satisfied customers.
Common Patient Complaints
The most common complaints tend to cluster around three operational themes rather than one single clinical issue.
1. Subscription Auto-Renewals and Billing Friction
One recurring source of dissatisfaction is the subscription model itself. Some users report frustration with auto-renewal timing, especially when they expected a pause, cancellation confirmation, or more obvious notice before the next charge processed. In telehealth, that type of complaint is not unique to Hims and Hers, but it matters because weight loss care is often ongoing and monthly billing can add up quickly.
From a cost-transparency standpoint, this means readers should pay close attention to:
- renewal cadence
- cancellation windows
- refill cutoff timing
- whether a medication shipment has already entered processing before a cancellation request is submitted
Consumers who are used to one-time online purchases may find the subscription mechanics less intuitive than expected.
2. Customer Service Wait Times
A second pattern in patient feedback involves customer service responsiveness. Users sometimes describe delays when trying to resolve billing questions, prescription updates, or shipping concerns during high-volume periods. This does not necessarily mean support is absent; rather, it suggests that an asynchronous, scaled telehealth model can feel slow when a patient wants immediate resolution.
That distinction matters in GLP-1 care because support delays can create anxiety around:
- missed refill windows
- dose-escalation timing
- side-effect questions
- order status confusion
- account changes after enrollment
Patients who prefer live phone-based support or highly personalized care coordination may find this model less reassuring than smaller, higher-touch programs.
3. Shipping and Fulfillment Logistics
The third major complaint area is shipping logistics. In online medication programs, the patient experience is tightly linked to pharmacy turnaround, packaging, tracking accuracy, and regional delivery conditions. Even when the prescribing workflow goes smoothly, delays in shipping can make the entire experience feel unreliable.
Reported issues in this category often include:
- slower-than-expected refill arrival
- unclear tracking updates
- confusion over prescription processing stages
- frustration when medication timing feels misaligned with the next dose cycle
That does not mean every patient experiences fulfillment problems. It means logistics are a real part of the value equation, especially for people who need predictable continuity.
What Patients Tend to Praise
Balanced against those complaints, many patients also highlight strengths that explain why Hims and Hers continues to attract a large user base.
Fast, Friction-Lite Onboarding
The platform’s onboarding flow is often praised for being fast, clean, and approachable. For first-time GLP-1 shoppers who do not want to schedule a traditional in-person appointment, the digital intake can feel dramatically simpler than navigating a local clinic or insurer-driven obesity medicine path.
Clean App Experience and Convenience
Patients who are comfortable with digital healthcare frequently appreciate the app-first design, secure messaging, refill visibility, and centralized account management. Busy professionals and parents often value the fact that much of the process can be handled on their own time without phone calls or office visits.
Broad Brand Recognition
Hims and Hers also benefits from strong mainstream brand awareness. For some buyers, that matters. A public company with a recognizable national name can feel more credible than a small telehealth startup, even if the operational experience is not flawless.
How to Interpret a 3.0/5 Trustpilot Score
A 3.0/5 Trustpilot average across 8,000+ reviews should not be read as proof that the service is bad, nor should it be ignored. It is better understood as a signal of mixed but meaningful real-world variability.
For consumers, the practical takeaway is:
- If you value speed, convenience, and digital simplicity, Hims and Hers may still feel like a strong fit.
- If you are highly sensitive to billing friction, support delays, or shipment timing, those risks deserve more weight in your decision.
- If you want a provider that feels more hands-on, with more clinical extras bundled into the monthly price, another program may deliver better perceived value even if its headline fee is not lower.
That mixed feedback profile is consistent with the platform’s Strong Choice tier. It is not presented here as flawless, but neither is it positioned as a caution-level provider. The strengths are real, and so are the tradeoffs.
Deeper Value Comparison: Hims/Hers vs. Mochi Health, Ivim Health, and Ro
Hims and Hers is easier to evaluate when placed beside other major telehealth options serving self-pay GLP-1 buyers. The right comparison is not simply “Who is cheapest?” but “What am I getting for the monthly spend?”
Mochi Health
Mochi Health takes a more bundled approach that will appeal to patients who want a flatter monthly cost structure. Its model is commonly framed around $79 per month plus flat-rate compounded medication pricing, which can make budgeting simpler than programs where membership and medication pricing feel more segmented or dosage-dependent. Another value add is that dietitian support is included, which can improve the overall package for patients who want more behavioral and nutrition guidance alongside a prescription.
Compared with Hims and Hers, Mochi may look stronger on bundled support. Hims and Hers, by contrast, may appeal more to users who prioritize brand familiarity, a polished consumer app, and a large-scale telehealth experience.
Ivim Health
Ivim Health is typically positioned at $149–$224 per month, depending on the plan structure and services selected. What makes Ivim notable in a pricing comparison is that the membership may include more clinical support infrastructure than Hims and Hers, including lab coordination, dietitian access, and insurance support. For patients who expect to need bloodwork review, nutrition coaching, or help navigating coverage, that added service layer can materially improve value even if the monthly fee is not lower on paper.
This is where the comparison becomes more nuanced. Hims and Hers can look streamlined and efficient for patients who already have outside labs or do not want a more hands-on model. But for someone starting from scratch and wanting a fuller obesity-care package, Ivim’s broader inclusion set may justify the higher monthly range.
Ro
Ro follows a different path from compounded-first or hybrid models because it is framed here as brand-name only, with $45 for the first month and then $145 per month, plus an insurance concierge workflow. That makes Ro particularly relevant for readers whose top priority is pursuing insured access to branded GLP-1 medications rather than focusing on compounded affordability.
Relative to Hims and Hers, Ro may be more attractive for patients who want structured help with coverage navigation and prior authorization support. Hims and Hers may feel simpler for pure self-pay shoppers, especially those comfortable with compounded options or who value the flexibility of a broad digital-health storefront. But if your decision hinges on whether someone will actively help you chase insurance approval for a brand-name GLP-1, Ro’s model may align more closely with that goal.
What This Means for Value
These three competitors highlight the key tradeoffs in Hims and Hers’ pricing model:
- Hims and Hers: Best for buyers who want a recognizable telehealth brand, a smooth app experience, and a self-pay-first workflow.
- Mochi Health: Stronger fit for patients who want lower-friction compounded pricing and built-in dietitian support.
- Ivim Health: Better fit for patients who want labs, nutrition support, and insurance-related help included in a more clinical package.
- Ro: Better aligned with patients focused on brand-name medication and insurance concierge support.
None of those comparisons changes Hims and Hers’ current Strong Choice positioning. Instead, they help explain who is most likely to find the platform’s pricing acceptable and who may be better served by a provider with more bundled services or more insurance-oriented support.
Frequently Asked Questions
1. Does the Hims and Hers $149 monthly membership fee include the cost of GLP-1 medications?
No. The $149 monthly membership fee covers your telehealth platform access, asynchronous medical consultations, ongoing care coordination, and 24/7 app support. Medication is billed separately based on whether you are prescribed compounded semaglutide or brand-name injectables like Wegovy, Ozempic, or Zepbound.
2. Are lab tests included in the Hims/Hers weight loss program?
No. Baseline and ongoing lab testing are not included in the standard membership fee. If your prescribing physician determines that blood work is medically necessary for your safety or dosage titration, you will need to complete and pay for labs independently through your primary care provider or an independent lab service.
3. What medications are available through Hims and Hers for weight loss?
Depending on clinical evaluation and availability, patients may be prescribed brand-name medications such as Ozempic, Wegovy, and Zepbound, or alternative formulations including compounded semaglutide and generic liraglutide.
4. Why does Hims and Hers have a 3.0/5 Trustpilot score?
The 3.0/5 Trustpilot average (based on over 8,000 reviews, as recorded April 2026) reflects individual consumer experiences: common criticisms across digital health platforms typically relate to subscription auto-renewals, customer support wait times during high-volume periods, and shipping logistics.
5. In how many states is the Hims/Hers weight loss program available?
Hims and Hers is available in a majority of U.S. states, but it is not available in all 50 states. State-by-state availability depends on local telehealth regulations and pharmacy board restrictions regarding compounded medications. Your eligibility is confirmed immediately during the online onboarding intake.
Conclusion
The Hims and Hers weight loss program represents a structured, technologically advanced option for self-pay consumers seeking metabolic health support. Backed by public company transparency (NYSE: HIMS) and a newly established March 2026 partnership with Novo Nordisk, the platform provides a reliable digital ecosystem. With an introductory rate of $39 for the first month followed by a $149 monthly membership fee, paired with flexible options ranging from compounded semaglutide to brand-name injectables, it stands as a Strong Choice for busy professionals and digital-first consumers.
However, patients must budget carefully for separate medication expenses, recognize that lab work and dietitian support are not bundled into the base subscription, and verify state-by-state availability before enrolling. By weighing these financial realities against your personal health goals, you can determine whether Hims and Hers is the right telehealth partner for your weight loss journey.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any medication or weight loss program.
Corrected 8 October 2026. An earlier version of this article said Mochi Health provides a certificate of analysis (CoA). That was our error, copied from our earlier Mochi review: its site does not offer one.
Corrected 9 October 2026. We removed 4 generated images from this article. Generated images on this site no longer show certifications, organisations, products, prices or figures unless the specific claim has been checked.
Corrected 14 October 2026: this article previously gave Better Business Bureau ratings for providers it compares, taken from our April 2026 research. We kept no record of where those ratings came from, so they have been removed.
Keep exploring our GLP-1 resources:
